Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-22

Clinical Trial Update: Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on probiotic treatment using Trichuris suis ova (TSO) for ulcerative colitis, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trichuris suis ova (TSO) probiotic treatment

Snippet

Sponsor: ParaTech A/S | Conditions: Ulcerative Colitis Chronic Moderate | Phase 2 | Status: COMPLETED